Skip to main content

Table 1 Clinical features at the first ultrasound examination of the skin of 75 SSc patients

From: High frequency ultrasound of skin involvement in systemic sclerosis – a follow-up study

Features

Median (IQR)

Age (years)

52.4 (44.8–62.0)

Disease duration (months)

10.9 (7.9–19.1)

mRSS

10.5 (4.0–19)

Serum-COMP (U/L)

12 (10–17) (n = 62)

HAMIS

6.0 (3.5–14) (n = 54)

 

n (%)

Women

62 (83)

lcSSc

42 (56)

Immunosuppressive treatment (yes/no)a

39/36 (52/48)

  1. mRSS modified Rodnan skin score, COMP cartilage oligomeric matrix protein, HAMIS hand mobility in scleroderma test, lcSSc limited cutaneous systemic sclerosis, dcSSc diffuse cutaneous systemic sclerosis
  2. aCyclophosphamide (n = 16); Azathioprine (n = 10); Methotrexate (n = 7); Mycophenylate mofetil (n = 12). Six patients received two different treatments during the first year of follow-up